Telomir Pharmaceuticals Inc
NASDAQ:TELO
Balance Sheet
Balance Sheet Decomposition
Telomir Pharmaceuticals Inc
Telomir Pharmaceuticals Inc
Balance Sheet
Telomir Pharmaceuticals Inc
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
5
+9 702%
|
1
-72%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+614%
|
1
+35%
|
1
-49%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
1
|
14
|
31
|
|
| Additional Paid In Capital |
0
|
0
|
18
|
31
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
-579%
|
3
N/A
|
1
-81%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
5
+9 702%
|
1
-72%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
30
|
30
|
29
|
30
|
|